Jinming Liu

Title: The Innovations of Inventor Jinming Liu

Introduction

Jinming Liu is a notable inventor based in Beijing, China, known for his contributions to the field of pharmaceuticals. With a total of two patents, his work primarily focuses on the inhibition of specific kinases, which play vital roles in various diseases.

Latest Patents

Liu's latest patents involve compounds that inhibit the activities of Bruton's tyrosine kinase (BTK) and Janus kinase 3 (JAK3). These inventions encompass pharmaceutical compositions, their applications, and methods for treating or preventing diseases linked to BTK and JAK3. The compounds he developed are geared towards beneficial effects in mammals, especially humans, highlighting their potential in medical treatment.

Career Highlights

Liu is affiliated with Beijing Hanmi Pharmaceutical Co., Ltd., where his research contributes significantly to the company's innovative pursuits in drug development. His patents represent critical advancements in pharmaceutical sciences, focusing on therapeutics aimed at combating illnesses associated with kinase activities.

Collaborations

Throughout his career, Liu has collaborated with esteemed colleagues such as Mi Young Cha and Gong Li. These partnerships enhance his innovative work and extend the scope of research conducted at Hanmi Pharmaceutical.

Conclusion

Jinming Liu's contributions to the pharmaceutical industry underscore the importance of innovation in medical research. His patented compounds represent a step forward in treating conditions influenced by BTK and JAK3, demonstrating the impact of dedicated inventors in improving health outcomes.